BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 15953401)

  • 1. The role of genetic counseling on decisions of pregnant women aged 35 years or over regarding amniocentesis in Turkey.
    Ilgin-Ruhi H; Yürür-Kutlay N; Tükün A; Bökesoy I
    Eur J Med Genet; 2005; 48(1):13-9. PubMed ID: 15953401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting the decision regarding amniocentesis in women at genetic risk because of age 35 years or older.
    Vergani P; Locatelli A; Biffi A; Ciriello E; Zagarella A; Pezzullo JC; Ghidini A
    Prenat Diagn; 2002 Sep; 22(9):769-74. PubMed ID: 12224068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiety and prenatal testing: do women with soft ultrasound findings have increased anxiety compared to women with other indications for testing?
    Hoskovec J; Mastrobattista JM; Johnston D; Kerrigan A; Robbins-Furman P; Wicklund CA
    Prenat Diagn; 2008 Feb; 28(2):135-40. PubMed ID: 18236427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of invasive prenatal diagnostic tests in women after detection of soft markers for chromosomal abnormality on ultrasonographic evaluation.
    Sharda S; Phadke SR
    J Perinatol; 2007 Sep; 27(9):550-5. PubMed ID: 17611609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiety engendered by amniocentesis.
    Beeson D; Golbus MS
    Birth Defects Orig Artic Ser; 1979; 15(5C):191-7. PubMed ID: 526602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological responses to prenatal NTS counseling and the uptake of invasive testing in women of advanced maternal age.
    Kaiser AS; Ferris LE; Katz R; Pastuszak A; Llewellyn-Thomas H; Johnson JA; Shaw BF
    Patient Educ Couns; 2004 Jul; 54(1):45-53. PubMed ID: 15210259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnant women of 35 years of age or more: maternal serum markers or amniocentesis?
    Antsaklis A; Papantoniou N; Mesogitis S; Michalas S; Aravantinos D
    J Obstet Gynaecol; 1999 May; 19(3):253-6. PubMed ID: 15512289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal diagnosis in 3,000 women for chromosome, X-linked, and metabolic disorders.
    Daniel A; Stewart L; Saville T; Brookwell R; Paull H; Purvis-Smith S; Lam-Po-Tang PR
    Am J Med Genet; 1982 Jan; 11(1):61-75. PubMed ID: 7065004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal diagnosis: chances, choices.
    Roberts SF
    J Fla Med Assoc; 1997; 84(6):374-8. PubMed ID: 9379162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of congenital anomalies at birth among offspring of women at risk for a genetic disorder and with a normal second-trimester ultrasound.
    Lemyre E; Infante-Rivard C; Dallaire L
    Teratology; 1999 Oct; 60(4):240-4. PubMed ID: 10508977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decisions about amniocentesis by advanced maternal age patients following maternal serum screening may not always correlate clinically with screening results: need for improvement in informed consent process.
    Marini T; Sullivan J; Naeem R
    Am J Med Genet; 2002 May; 109(3):171-5. PubMed ID: 11977174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-trimester minor ultrasound anomalies: impact on the risk of aneuploidy associated with advanced maternal age.
    Drugan A; Johnson MP; Reichler A; Hume RF; Itskovicz-Eldor J; Evans MI
    Obstet Gynecol; 1996 Aug; 88(2):203-6. PubMed ID: 8692502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-specific incidences of chromosome abnormalities at the second trimester amniocentesis for Japanese mothers aged 35 and older: collaborative study of 5484 cases.
    Yaegashi N; Senoo M; Uehara S; Suzuki H; Maeda T; Fujimori K; Hirahara F; Yajima A
    J Hum Genet; 1998; 43(2):85-90. PubMed ID: 9621511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should all pregnant patients be offered prenatal diagnosis regardless of age?
    Druzin ML; Chervenak F; McCullough LB; Blatman RN; Neidich JA
    Obstet Gynecol; 1993 Apr; 81(4):615-8. PubMed ID: 8459978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of first-trimester screening on AMA patients' uptake of invasive testing.
    Wray AM; Ghidini A; Alvis C; Hodor J; Landy HJ; Poggi SH
    Prenat Diagn; 2005 May; 25(5):350-3. PubMed ID: 15906421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prenatal cytogenetic diagnosis in older pregnant women].
    Kalina I; Ondrusseková A; Lukacín S; Konecná H; Fialová B; Herman M
    Cesk Gynekol; 1993 Dec; 58(6):283-5. PubMed ID: 8293504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors in a woman's decision to undergo genetic amniocentesis for advanced maternal age.
    Davies BL; Doran TA
    Nurs Res; 1982; 31(1):56-9. PubMed ID: 6214766
    [No Abstract]   [Full Text] [Related]  

  • 18. [Investigation of the incidence of aberration in various indication for prenatal cytogenetic analysis].
    Matsuo T; Hisanaga S; Maeda H; Tukimori K; Matsuo K; Nagata H; Nakano H
    Fukuoka Igaku Zasshi; 1992 Oct; 83(10):377-82. PubMed ID: 1464405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province].
    Hu YL;
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2476-80. PubMed ID: 18067809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal chromosomal analysis of pregnancies following intracytoplasmic sperm injection with amniotic tissue culture.
    Samli H; Solak M; Imirzalioglu N; Beyatli Y; Simşek S; Kahraman S
    Prenat Diagn; 2003 Oct; 23(10):847-50. PubMed ID: 14558031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.